A carregar...
Potential role of daratumumab in the treatment of multiple myeloma
Multiple myeloma is the second most common hematologic malignancy in the US. Treatments utilizing alkylating agents, corticosteroids, proteasome inhibitors, and immunomodulatory drugs have resulted in significant survival benefits, however, despite the advances, relapse is inevitable. Decreased dept...
Na minha lista:
Main Authors: | , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Dove Medical Press
2014
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4069139/ https://ncbi.nlm.nih.gov/pubmed/24971019 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S49480 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|